XG
Exagen Inc.
XGN · NASDAQ
$7.58 +2.43% (+$0.18)
1M +14.16%
Market Cap $182.2M
P/E Ratio -
Div. Yield -
ROE 121.62%
Bulios Fair Price
$6.91
8.8% downside
Trenutna cena
$7.58
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica XGN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
33 /100
Expensive P/B 14.91x
P/S 2.56x
EV/EBITDA N/A
Growth
63 /100
Stable Book val. growth 25.65%
Rev. growth 13.47%
FCF growth N/A
Profitability
20 /100
Weak Net margin 26.61%
Op. margin 18.58%
FCF margin 10.67%
Quality
15 /100
Poor ROE 121.62%
ROA 36.44%
Asset turnover 1.37x
Debt
30 /100
High Current ratio 3.18x
Int. coverage -2.69x
Debt/Equity 2.09x
Stability
49 /100
Moderate Rev. volatility 7.04%
EPS volatility 33.54%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XGN
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
John Aballi
Employees
216
Headquarters
Vista
Prihajajoči dogodki
03 NOV.
Earnings
Upcoming earnings report